111 related articles for article (PubMed ID: 16821214)
21. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.
Ueno T; Endo S; Saito R; Hirose M; Hirai S; Suzuki H; Yamato K; Hyodo I
Oncol Res; 2013; 21(3):155-64. PubMed ID: 24512730
[TBL] [Abstract][Full Text] [Related]
22. Proglumide, a gastrin receptor antagonist, inhibits growth of colon cancer and enhances survival in mice.
Beauchamp RD; Townsend CM; Singh P; Glass EJ; Thompson JC
Ann Surg; 1985 Sep; 202(3):303-9. PubMed ID: 2994583
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells.
Li J; Hou N; Faried A; Tsutsumi S; Takeuchi T; Kuwano H
Ann Surg Oncol; 2009 Mar; 16(3):761-71. PubMed ID: 19116755
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of in vitro cytotoxicity of oxaliplatin and 5-fluorouracil in human colon cancer cell lines: combination versus sequential exposure.
Failli A; Consolini R; Legitimo A; Orsini G; Romanini A; Spisni R; Castagna M; Miccoli P
J Biol Regul Homeost Agents; 2011; 25(4):575-88. PubMed ID: 22217990
[TBL] [Abstract][Full Text] [Related]
25. The c-MYC-ABCB5 axis plays a pivotal role in 5-fluorouracil resistance in human colon cancer cells.
Kugimiya N; Nishimoto A; Hosoyama T; Ueno K; Enoki T; Li TS; Hamano K
J Cell Mol Med; 2015 Jul; 19(7):1569-81. PubMed ID: 25689483
[TBL] [Abstract][Full Text] [Related]
26. Combination of 5-fluorouracil and irinotecan on modulation of thymidylate synthase and topoisomerase I expression and cell cycle regulation in human colon cancer LoVo cells: clinical relevance.
Xu JM; Azzariti A; Tommasi S; Lacalamita R; Colucci G; Johnston PG; Church SW; Paradiso A
Clin Colorectal Cancer; 2002 Nov; 2(3):182-8. PubMed ID: 12482336
[TBL] [Abstract][Full Text] [Related]
27. [Lidamycin inhibits the proliferation of HERG K+ channel highly expressing cancer cells and shows synergy with anticancer drugs].
Shang BY; Shang Y; Zhen YS; Chen SZ
Yao Xue Xue Bao; 2011 Nov; 46(11):1321-5. PubMed ID: 22260022
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of recombinant interferon-alpha and 5-fluorouracil against colon cancer cells or against peripheral blood mononuclear cells.
De Filippi R; Prete SP; Giuliani A; Silvi E; Yamaue H; Nieroda CA; Greiner JW; De Vecchis L; Bonmassar E
Anticancer Res; 1994; 14(5A):1767-73. PubMed ID: 7847809
[TBL] [Abstract][Full Text] [Related]
29. Schedule-dependent cytotoxicity of 5-fluorouracil and irinotecan in p53 mutant human colon cancer.
Tanaka K; Inoue Y; Hiro J; Yoshiyama S; Toiyama Y; Eguchi T; Miki C; Kusunoki M
J Exp Clin Cancer Res; 2007 Jun; 26(2):241-51. PubMed ID: 17725105
[TBL] [Abstract][Full Text] [Related]
30. An acellular tissue matrix-based drug carriers with dual chemo-agents for colon cancer growth suppression.
Qin C; Shen Y; Wang B; Zhao X; Liu Y; Yang S; Chen J
Biomed Pharmacother; 2019 Sep; 117():109048. PubMed ID: 31181443
[TBL] [Abstract][Full Text] [Related]
31. Anti-tumour effects of triple therapy with octreotide, galanin and serotonin in comparison with those of 5-fluorouracil/leukovorin on human colon cancer.
Tjomsland V; El-Salhy M
Int J Oncol; 2005 Aug; 27(2):427-32. PubMed ID: 16010424
[TBL] [Abstract][Full Text] [Related]
32. Effects of melatonin and melatonin receptors ligand N-[(4-methoxy-1H-indol-2-yl)methyl]propanamide on murine Colon 38 cancer growth in vitro and in vivo.
Winczyk K; Pawlikowski M; Lawnicka H; Kunert-Radek J; Spadoni G; Tarzia G; Karasek M
Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():50-4. PubMed ID: 12019352
[TBL] [Abstract][Full Text] [Related]
33. [Inhibitory effects of TNP-470 in combination with 5-fluorouracil on growth of human colon cancer].
Fan YF; Huang ZH; Nie J
Ai Zheng; 2002 Dec; 21(12):1319-23. PubMed ID: 12520739
[TBL] [Abstract][Full Text] [Related]
34. Comparison between CoFactor and Leucovorin activity applied in combination with 5-fluorouracil against two human colon cancer cell lines.
Bjelogrlić SK; Srdić T; Radulović S
J BUON; 2007; 12(1):71-6. PubMed ID: 17436405
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of pentagastrin-stimulated up-regulation of gastrin receptors and growth of mouse colon tumor in vivo by proglumide, a gastrin receptor antagonist.
Singh P; Le S; Beauchamp RD; Townsend CM; Thompson JC
Cancer Res; 1987 Oct; 47(19):5000-4. PubMed ID: 3621187
[TBL] [Abstract][Full Text] [Related]
36. Synergistic Growth Inhibition of HT-29 Colon and MCF-7 Breast Cancer Cells with Simultaneous and Sequential Combinations of Antineoplastics and CNS Drugs.
Duarte D; Cardoso A; Vale N
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299028
[TBL] [Abstract][Full Text] [Related]
37. Synergistic anticancer properties of docosahexaenoic acid and 5-fluorouracil through interference with energy metabolism and cell cycle arrest in human gastric cancer cell line AGS cells.
Gao K; Liang Q; Zhao ZH; Li YF; Wang SF
World J Gastroenterol; 2016 Mar; 22(10):2971-80. PubMed ID: 26973393
[TBL] [Abstract][Full Text] [Related]
38. Diurnal variation in the therapeutic efficacy of 5-fluorouracil against murine colon cancer.
Peters GJ; Van Dijk J; Nadal JC; Van Groeningen CJ; Lankelma J; Pinedo HM
In Vivo; 1987; 1(2):113-7. PubMed ID: 2979771
[TBL] [Abstract][Full Text] [Related]
39. Different effects of sequential combinations of N-methylformamide with 5-fluorouracil on human colon carcinoma cells growing in nude mice.
Arancia G; Leonetti C; Malorni W; Greco C; Formisano G; Marangolo M; Zupi G
J Cancer Res Clin Oncol; 1991; 117(4):351-8. PubMed ID: 2066356
[TBL] [Abstract][Full Text] [Related]
40. Effect of selenite combined with chemotherapeutic agents on the proliferation of human carcinoma cell lines.
Schroeder CP; Goeldner EM; Schulze-Forster K; Eickhoff CA; Holtermann P; Heidecke H
Biol Trace Elem Res; 2004; 99(1-3):17-25. PubMed ID: 15235138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
